Reape Kathleen 4
4 · Taysha Gene Therapies, Inc. · Filed Nov 24, 2020
Insider Transaction Report
Form 4
Reape Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-23+31,000→ 31,000 totalExercise: $21.77Exp: 2030-11-23→ Common Stock (31,000 underlying)
Footnotes (1)
- [F1]The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date.